Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 9601493, 8 pages
http://dx.doi.org/10.1155/2016/9601493
Research Article

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy

1Department of Oncology, Aarhus University Hospital, 8000 Aarhus C, Denmark
2Department of Clinical Biochemistry, Aarhus University Hospital, 8000 Aarhus C, Denmark
3Laboratory for Molecular Endocrinology (KMEB), Department of Endocrinology, Odense University Hospital, 5000 Odense, Denmark
4Danish Stem Cell Center (DanStem), Panum Institute, University of Copenhagen, 2200 Copenhagen, Denmark

Received 15 June 2015; Revised 20 August 2015; Accepted 23 August 2015

Academic Editor: Dominik Wolf

Copyright © 2016 Ninna Aggerholm-Pedersen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Jia-Lin Yang, Romi Das Gupta, David Goldstein, and Philip J. Crowe, “Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue Sarcoma,” International Journal of Molecular Sciences, vol. 18, no. 6, pp. 1159, 2017. View at Publisher · View at Google Scholar
  • Wang-Qing Liu, Yves Lepelletier, Matthieu Montes, Lucia Borriello, Rafika Jarray, Renaud Grepin, Bertrand Leforban, Ali Loukaci, Rachid Benhida, Olivier Hermine, Sylvie Dufour, Gilles Pages, Christiane Garbay, Françoise Raynaud, Reda Hadj-Slimane, and Luc Demange, “NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model,” Cancer Letters, 2017. View at Publisher · View at Google Scholar